MALVERN, Pa., Feb. 3 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, just announced that it has received marketing approval from the U.S. Food and ...

Auxilium Pharmaceuticals has announced plans to invest in an indication for prescription drug Xiaflex (collagenase clostridium histolyticum), which was approved by FDA in February 2010 for adult ...

DUBLIN, Jan. 24, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase Clostridium Histolyticum for ...

BioSpecifics Technologies announced positive results from its Phase 3b MULTICORD study evaluating Xiaflex (collagenase clostridium histolyticum) for the concurrent treatment of adult Dupuytren’s ...

MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. (NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment with ...

The US Food and Drug Administration (FDA) has expanded the approval of collagenase clostridium histolyticum (HCC; Xiaflex, Auxillium Pharmaceuticals) for the treatment of up to two Dupuytren's ...

This marks the first live procedure at AAHS, as well as a first for Keenova. Treatment takes place over two days of annual meeting—injection on Wednesday and finger extension on Friday. Audience of ...

The U.S. Food and Drug Administration today approved a new use for Xiaflex (collagenase clostridium histolyticum) as the first FDA-approved medicine to treat men with bothersome curvature of the penis ...

The Food and Drug Administration (FDA) has approved Xiaflex as the first non-surgical treatment for Peyronie’s disease (PD), a condition that causes penis curvature that can make sexual intercourse ...

Shares of Auxilium Pharmaceuticals Inc. climbed 17.4 percent Wednesday on news that the FDA had approved Xiaflex (collagenase Clostridium histolyticum) as the first drug in the U.S. to treat Dupuytren ...